11.40
+0.30
+(2.70%)
As of 8:16:34 AM GMT+1. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
BOLNO PAUL B. M.D. Chief Executive Officer | Conversion of Exercise of derivative security | Nov 25, 2024 | 217,351 |
CORRIGAN MARK Director | Stock Award(Grant) | Aug 12, 2024 | 32,230 |
FRANCIS CHRISTOPHER JOHN Officer | Conversion of Exercise of derivative security | Nov 8, 2024 | 0 |
GSK PLC Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 27, 2024 | -- |
HENRY CHRISTIAN O Director | Stock Award(Grant) | Aug 12, 2024 | 16,115 |
MORAN KYLE Chief Financial Officer | Conversion of Exercise of derivative security | Oct 11, 2024 | 44,777 |
RAWCLIFFE ADRIAN Director | Stock Award(Grant) | Aug 12, 2024 | 16,115 |
VARGEESE CHANDRA Officer | Conversion of Exercise of derivative security | Jan 23, 2025 | 233,933 |
VERDINE GREGORY L Director | Stock Award(Grant) | Aug 12, 2024 | 46,115 |
WAGNER HEIDI L Director | Stock Award(Grant) | Aug 12, 2024 | 32,230 |
Related Tickers
9IP1.F Rocket Pharmaceuticals, Inc.
9.94
+3.37%
0K4.BE Akero Therapeutics Inc
52.12
-3.01%
BBZA.F BB Biotech AG Ord
43.60
+2.35%
0K4.F Akero Therapeutics, Inc.
53.02
+2.71%
COYA Coya Therapeutics, Inc.
6.00
+2.39%
22UA.DE BioNTech SE
118.40
-0.17%
MTEM Molecular Templates, Inc.
0.0003
0.00%
EDSA Edesa Biotech, Inc.
1.9599
+3.80%
ANIX Anixa Biosciences, Inc.
2.8600
-2.72%
MGNX MacroGenics, Inc.
3.0802
+2.33%